Fatih Özdener

Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop and Go' Study Results - A Turkish Oncology Group Trial

Şuayib Yalçın, Rüçhan Uslu, Faysal Dane et al. · Oncology · 2013 · 70 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies

Vahit Özmen, Şükrü Boylu, Engin Ok et al. · European Journal of Public Health · 2014 · 67 citations · Full text

Medicine, Oncology, Breast Oncology +12

Activation of Phospholipase Cγ2 by Tyrosine Phosphorylation

Fatih Özdener, Carol Dangelmaier, Barrie Ashby et al. · Molecular Pharmacology · 2002 · 64 citations

Life Sciences, Biochemistry, Molecular Biology +15

Glycoprotein VI–mediated platelet fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP

Todd M. Quinton, Fatih Özdener, Carol Dangelmaier et al. · Blood · 2002 · 58 citations

Medicine, Biochemistry, Molecular Biology +16

Functional role of the spatial proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the μ opioid receptor

Wei Xu, Fatih Özdener, Jianguo Li et al. · FEBS Letters · 1999 · 47 citations

Medicine, Pharmacology, Molecular Pharmacology +16